Dietrich Stephan

Dietrich Stephan

Chairman presso Peptilogics, Inc.

Patrimonio netto: 107 173 $ in data 31/03/2024

54 anni
Consumer Services
Health Technology
Commercial Services

Profilo

Dietrich A.
Stephan
is the founder of Amnestix, Inc. (founded in 2006), Life Technologies Clinical Services Lab, Inc. (founded in 2006), Lifecode, Inc. (founded in 2011), and NeuBase Therapeutics, Inc. (founded in 2009).
He held the titles of Director-Neurogenomics Division at Amnestix, Inc., Director & Chief Scientific Officer at Life Technologies Clinical Services Lab, Inc., President, Chief Executive Officer & Director at Lifecode, Inc., and Chief Executive Officer & Director at NeuBase Therapeutics, Inc. Dr. Stephan was also the founder of DiaVacs, Inc., LifeX Holdings LLC.
His current job(s) include Chairman-Neuroscience Microarray Consortium at the National Institutes of Health, Chairman at Peptilogics, Inc., Director at FRX Growth Partners LLC, Director at Epistemix, Inc., Member at the National Institute of Health Policy, and Partner at Cyto Ventures.
His former job(s) include President & Chief Executive Officer at Neubase Therapeutics, Inc., Chairman-Neurogenomics Department & Professor at the Translational Genomics Research Institute, Director at Western Oncolytics Ltd., Executive Director-Gene Partnership at The Children's Hospital Corp.
and Harvard Medical School, Director at Personalized Medicine Coalition, Director at Sharp Edge Labs, Inc., Director at iGenomX International Genomics LLC, Director at Parabase Genomics, Inc., Director at Ariel Precision Medicine, Inc., Director at Pendulum Therapeutics, Inc., Director at CereDx, Inc., Professor at the University of Pittsburgh, Faculty Member at George Washington University, Arizona State University, The Johns Hopkins University, and the University of Arizona, and Chief Science Advisor at FarmaceuticalRX LLC.
His education includes an undergraduate degree from Carnegie Mellon University and a doctorate degree from the University of Pittsburgh Graduate School of Public Health.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
04/08/2023 238 162 ( 6.39% ) 107 173 $ 31/03/2024

Posizioni attive di Dietrich Stephan

SocietàPosizioneInizio
National Institute of Health Policy Corporate Officer/Principal -
Corporate Officer/Principal 26/07/2011
Chairman 01/04/2016
Cyto Ventures Corporate Officer/Principal -
Director/Board Member -
Director/Board Member -
Tutte le posizioni attive di Dietrich Stephan

Precedenti posizioni note di Dietrich Stephan

SocietàPosizioneFine
NEUBASE THERAPEUTICS, INC. Chief Executive Officer 16/01/2024
Director/Board Member 01/08/2018
Founder 01/04/2011
░░░░░ ░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Vedi nel dettaglio l'esperienza di Dietrich Stephan

Formazione di Dietrich Stephan

Carnegie Mellon University Undergraduate Degree
University of Pittsburgh Graduate School of Public Health Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Dietrich Stephan

Relazioni

100 +

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
NEUBASE THERAPEUTICS, INC.

Health Technology

Aziende private23

Health Technology

Health Technology

Health Technology

Health Services

Government

Commercial Services

Health Services

National Institute of Health Policy

Commercial Services

Commercial Services

Technology Services

Health Technology

Commercial Services

Health Services

Health Services

Health Technology

Process Industries

Health Technology

Process Industries

LifeX Holdings LLC

Cyto Ventures

Commercial Services

Technology Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Dietrich Stephan